Naropin and Fall - a phase IV clinical study of FDA data

Summary:

Fall is reported as a side effect among people who take Naropin (ropivacaine hydrochloride monohydrate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Synthroid, and have Local anaesthesia.

The phase IV clinical study analyzes which people have Fall when taking Naropin. It is created by eHealthMe based on reports of 1,155 people who have side effects when taking Naropin from the FDA, and is updated regularly.

What is Naropin?

Naropin has active ingredients of ropivacaine hydrochloride monohydrate. eHealthMe is studying from 1,156 Naropin users. Check the latest studies of Naropin.

What is Fall?

Fall is found to be associated with 3,248 drugs and 3,757 conditions by eHealthMe. Check the latest studies of Fall.

On Jul, 09, 2026

1,155 people reported to have side effects when taking Naropin.
Among them, 13 people (1.13%) have Fall.

Among these 13 people:

How long have people been on Naropin when they have Fall? *

What is the gender of people who have Fall when taking Naropin? *

female: 53.85 %
male: 46.15 %

What is the age of people who have Fall when taking Naropin? *

What are other drugs people take besides Naropin? *

What are other side effects people have besides Fall? *

Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 3 people, 23.08%
Catatonia (unresponsive to external stimuli): 2 people, 15.38%
Neck Pain: 2 people, 15.38%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 15.38%
Loss Of Consciousness: 2 people, 15.38%
Head Injury: 2 people, 15.38%
Eye Injury: 2 people, 15.38%
Memory Loss: 2 people, 15.38%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 2 people, 15.38%
Cerebral Haemorrhage (bleeding within the brain): 2 people, 15.38%

What are the existing conditions these people have? *

Pain: 3 people, 23.08%
Local Anaesthesia: 3 people, 23.08%
Iron Deficiency: 2 people, 15.38%
Cholinergic Syndrome (symptoms of increased cholinergic stimulation): 2 people, 15.38%
Neuropathy Peripheral (surface nerve damage): 2 people, 15.38%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 15.38%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 2 people, 15.38%
Multiple Allergies (allergy to multiple agents): 2 people, 15.38%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 15.38%
Blood Glucose Abnormal: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Naropin and have Fall?

- Check whether Fall is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Naropin:

Naropin (1,156 reports)

Fall treatments and more:

Fall (403,513 reports)

How severe was Fall and when was it recovered:

Fall in Naropin

Expand to all the drugs that have ingredients of ropivacaine hydrochloride monohydrate:

Fall and drugs with ingredients of ropivacaine hydrochloride monohydrate (17 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Naropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fall:

Fall (3,248 drugs)

Browse all the conditions that are associated with Fall:

Fall (3,757 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ropivacaine hydrochloride monohydrate (the active ingredients of Naropin) and Naropin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.